当前位置: X-MOL 学术Lancet Haematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pembrolizumab plus single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma
The Lancet Haematology ( IF 15.4 ) Pub Date : 2024-06-25 , DOI: 10.1016/s2352-3026(24)00168-6
Kenshi Suzuki 1
Affiliation  



中文翻译:


帕博利珠单抗联合单次放疗治疗复发或难治性多发性骨髓瘤患者


更新日期:2024-06-25
down
wechat
bug